Galapagos NV
GLPG
#4738
Rank
C$2.75 B
Marketcap
C$41.03
Share price
-1.14%
Change (1 day)
19.50%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2025 (TTM): -C$0.75 Billion

According to Galapagos NV's latest financial reports the company's current earnings are C$0.32 Billion. In 2024 the company made an earning of -C$8.06 Million, an increase over its 2023 earnings that were of -C$46.78 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.75 Billion9137.38%
2024 -C$8.06 Million-82.77%
2023 -C$46.78 Million-85.59%
2022 -C$0.33 Billion60.71%
2021 -C$0.21 Billion-60.08%
2020 -C$0.51 Billion-331.44%
2019 C$0.21 B-523.76%
2018 -C$51.61 Million-72.34%
2017 -C$0.19 Billion-329.59%
2016 C$81.26 M-144.3%
2015 -C$0.19 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$46.79 B-6,402.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$11.80 B-1,690.17%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$9.20 B-1,339.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.73 B-1,546.16%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$31.27 B-4,311.72%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$19.67 B-2,749.91%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$13.80 B-1,958.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-C$74.58 Million-89.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$3.00 B-504.21%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel